Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 3”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04382937
What this trial is testing

Ropeginterferon Alfa-2b (P1101) Phase 3 Study in Interferon Treatment-Naive Subjects With HCV Genotype 2 Infection

Who this might be right for
Chronic Hepatitis C Virus Infection
PharmaEssentia 222
Not applicableActive Not RecruitingNCT07316842
What this trial is testing

SVR12 in Genotype 3 HCV (F0-F2) Treated With RDV + SOF

Who this might be right for
Viral Hepatitis C
Center of target therapy 30
Large-scale testing (Phase 3)Study completedNCT02640157
What this trial is testing

A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C VirusGenotype 3 Hepatitis C Virus
AbbVie 506
Large-scale testing (Phase 3)Study completedNCT02319031
What this trial is testing

Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 53
Large-scale testing (Phase 3)Study completedNCT02201953
What this trial is testing

Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 558
Not applicableStudy completedNCT03303599
What this trial is testing

Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6

Who this might be right for
Hepatitis C
AbbVie 2,118
Testing effectiveness (Phase 2)Study completedNCT02094443
What this trial is testing

Alisporivir With RBV in Chronic Hepatitis C Genotype 2 and 3 Participants for Whom Interferon is Not an Option

Who this might be right for
Hepatitis CLiver Disease
Debiopharm International SA 52
Large-scale testing (Phase 3)Ended earlyNCT01866930
What this trial is testing

Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV

Who this might be right for
Chronic Hepatitis C Infection
Bristol-Myers Squibb 453
Testing effectiveness (Phase 2)Study completedNCT02292719
What this trial is testing

Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C Virus Infection
AbbVie 70
Large-scale testing (Phase 3)Study completedNCT00705432
What this trial is testing

Safety and Efficacy of Boceprevir in Previously Untreated Subjects With Chronic Hepatitis C Genotype 1 (Study P05216AM2) (COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 1,472
Large-scale testing (Phase 3)Study completedNCT00623428
What this trial is testing

Combination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 235
Not applicableEnded earlyNCT02464631
What this trial is testing

To Evaluate the Safety and Efficacy of Sofosbuvir and Ribavirin in Patients With HCV (Genotype 3) Related Decompensated Cirrhosis

Who this might be right for
HCV Related Cirrhosis
Institute of Liver and Biliary Sciences, India 62
Not applicableStudy completedNCT00933127
What this trial is testing

S8809-S9800-S9911-S9704-A Study of Blood and Tissue Samples From Patients With Follicular Lymphoma Treated With Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone

Who this might be right for
Lymphoma
SWOG Cancer Research Network 142
Post-approval studies (Phase 4)Study completedNCT01364090
What this trial is testing

A Collaborative Trial in Injectors of Individualized Treatment for Genotype 2/3

Who this might be right for
Hepatitis C, Chronic
Kirby Institute 93
Testing effectiveness (Phase 2)Ended earlyNCT02759315
What this trial is testing

Efficacy and Safety of Uprifosbuvir (MK-3682) With Ruzasvir (MK-8408) in Adults With Chronic Hepatitis C Genotype 1, 2, 3, 4, 5 or 6 Infection (MK-3682-035)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 160
Large-scale testing (Phase 3)Study completedNCT02973503
What this trial is testing

Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, With Non-severe Fibrosis

Who this might be right for
Chronic HCV Infection
University Hospital, Clermont-Ferrand 117
Testing effectiveness (Phase 2)Study completedNCT01826981
What this trial is testing

Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 359
Large-scale testing (Phase 3)Study completedNCT00780416
What this trial is testing

Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Tanabe Pharma Corporation 189
Testing effectiveness (Phase 2)Ended earlyNCT01433133
What this trial is testing

Safety and Biological Activity of InfraDure Biopump Secreting Sustained Interferon in HCV Patients

Who this might be right for
Hepatitis C
Medgenics Medical Israel Ltd. 3
Early research (Phase 1)Study completedNCT03072056
What this trial is testing

A Pharmacokinetic Study of MIN-101 and Its Metabolites in Healthy Subjects to Compare MIN-101 in Poor and Extensive Metabolizers

Who this might be right for
Healthy Subjects
Minerva Neurosciences 23
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation